Embla Medical hf.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OSSFF research report →
About the company
Embla Medical hf is a global enterprise dedicated to the orthopaedic sector. Its primary focus involves the conceptualization, progression, manufacturing, and international distribution of non-surgical orthopaedic solutions. The company's business activities are geographically divided into three main regions: the Americas; Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific territory.
- CEO
- Sveinn Solvason
- IPO
- 2019
- Employees
- 4,000
- HQ
- Reykjavik, IS
Price Chart
- Market Cap
- $1.77B
- P/E
- 18.96
- P/S
- 1.69
- P/B
- 1.80
- EV/EBITDA
- 11.07
- Div Yield
- 0.00%
- Gross Margin
- 58.89%
- Op Margin
- 13.16%
- Net Margin
- 8.93%
- ROE
- 9.82%
- ROIC
- 6.41%
- Revenue
- $963.59M · 12.72%
- Net Income
- $86.47M · 26.64%
- EPS
- $0.20 · 25.00%
- Op Income
- $129.38M
- FCF YoY
- 54.79%
- 52W High
- $5.33
- 52W Low
- $4.15
- 50D MA
- $4.15
- 200D MA
- $4.68
- Beta
- 0.45
- Avg Volume
- 156.1
Get TickerSpark's AI analysis on OSSFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OSSFF coverage
Recent articles, reports, and earnings notes.
No research on OSSFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OSSFF report →Similar companies
Peers in the same neighborhood.